1. Home
  2. ICL vs HALO Comparison

ICL vs HALO Comparison

Compare ICL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICL
  • HALO
  • Stock Information
  • Founded
  • ICL 1968
  • HALO 1998
  • Country
  • ICL Israel
  • HALO United States
  • Employees
  • ICL N/A
  • HALO N/A
  • Industry
  • ICL Agricultural Chemicals
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ICL Industrials
  • HALO Health Care
  • Exchange
  • ICL Nasdaq
  • HALO Nasdaq
  • Market Cap
  • ICL 8.7B
  • HALO 7.4B
  • IPO Year
  • ICL N/A
  • HALO N/A
  • Fundamental
  • Price
  • ICL $6.64
  • HALO $56.07
  • Analyst Decision
  • ICL Hold
  • HALO Buy
  • Analyst Count
  • ICL 2
  • HALO 9
  • Target Price
  • ICL $6.75
  • HALO $63.56
  • AVG Volume (30 Days)
  • ICL 719.5K
  • HALO 3.5M
  • Earning Date
  • ICL 05-19-2025
  • HALO 05-06-2025
  • Dividend Yield
  • ICL 2.78%
  • HALO N/A
  • EPS Growth
  • ICL N/A
  • HALO 55.40
  • EPS
  • ICL 0.30
  • HALO 3.76
  • Revenue
  • ICL $6,873,000,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • ICL $4.71
  • HALO $25.77
  • Revenue Next Year
  • ICL $4.08
  • HALO $18.01
  • P/E Ratio
  • ICL $21.99
  • HALO $14.92
  • Revenue Growth
  • ICL N/A
  • HALO 25.64
  • 52 Week Low
  • ICL $3.79
  • HALO $42.01
  • 52 Week High
  • ICL $6.95
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • ICL 54.17
  • HALO 48.34
  • Support Level
  • ICL $6.28
  • HALO $54.00
  • Resistance Level
  • ICL $6.69
  • HALO $55.25
  • Average True Range (ATR)
  • ICL 0.12
  • HALO 2.53
  • MACD
  • ICL -0.03
  • HALO 0.14
  • Stochastic Oscillator
  • ICL 52.99
  • HALO 42.01

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: